With more and more people signing up for weight loss drugs, the potential side effects are starting to attract attention.

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.

Findings showed a 13.6% reduction in body weight in the semaglutide 25 mg group compared with a 2.2% reduction in the placebo group.

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...

With pharmaceutical GLP-1 drugs like semaglutide in high demand, Metamorphx offers a plant-based alternative designed to ...

Interest in weight-loss products continues to surge as calls come for a faster rollout of treatments on the NHS. Research by ...

Western blot and real-time quantitative reverse transcription polymerase chain reaction were used to analyze the mRNA and protein expression of genes related to HO-1, SIRT1, the TGF-ß signaling ...

Their findings center on ZIP4, a protein that transports zinc throughout ... patients in the laboratory that mimic the original structure and the molecular property of the parental tumor as ...

Apr. 28, 2025 — New research sheds light on an understudied area of science: iron levels in the blood and their relationship to cognitive performance in women transitioning into menopause. The ...

Pantoprazole is used for the shortterm treatment of erosive esophagitis associated with gastroesophageal reflux disease. [2] It is available as a lyophilized powder for injection in 10-mL glass ...